Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 3
×
Leukemia, B-Cell
×
ofatumumab
×
Clear all
Filters
3
NCT01039376
2019-07-30
PROLONG
Novartis
Phase 3
Terminated
480 enrolled
30 charts
NCT00748189
2019-06-25
COMPLEMENT 1
Novartis
Phase 3
Terminated
447 enrolled
32 charts
NCT01678430
2012-10-15
RIAltO
University of Liverpool
Phase 3
Unknown
670 enrolled